News

Undeterred by challenges, Ola Electric keeps its sights forward, rolling out fresh products and next-gen models to stay in ...
According to IANS, Ola Electric has delayed the shipment of the Roadster X once again. This is the third occasion when deliveries of the electric bike have been delayed. After launching on ...
Ola, the Indian electric two wheeler manufacturer had launched the Roadster X series in February, this year. The brand's first ever electric motorcycle was slated to commence delivery from March ...
The latest development comes as Ola continues to lose ground in the ride-hailing space. Rapido has emerged as the market leader, rapidly expanding market leadership in bike taxis to its auto ...
Ola Electric has commenced test rides for its highly anticipated electric motorcycle, the Roadster X, shortly after ...
ANI shareholders such as Warburg Pincus, Vanguard, Steadview Capital and DST Global do not have stakes in Ola Electric and Krutrim AI. As Bhavish Aggarwal pushes ahead with the restructuring of ...
Ola Electric reported a challenging Q4 FY25 with widening losses and a sharp drop in revenue, driven by regulatory hurdles ...
Sona BLW remains optimistic despite US tariffs, citing past resilience, strong order book, and robust financials. CEO predicts industry consolidation, with weaker players exiting and stronger ...
VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA ...
As shares of electric two-wheeler making company Ather Energy Ltd debuted on the stock exchanges on Tuesday, its rival Ola Electric's founder Bhavish Aggarwal posted a heartwarming message on ...
Your browser does not support the audio element. After wrapping up FY2025 with record sales of 1.14 million units, electric two-wheeler manufacturers in India have ...
VANCOUVER and HALIFAX — BioVaxys Technology Corp. and Sona Nanotech Inc. announce that they have entered into a Research Agreement to collaborate on the development of new cancer therapeutics ...